Humana Inc (NYSE:HUM) stock fell as much as 7.5% before trimming losses to 4% following a court ruling against the health insurer in its Medicare bonus payment lawsuit. The decision also impacted ...

Goldman Sachs stock rises 20% YTD, outpacing the S&P 500. Analysts suggest holding GS due to its high momentum but caution on ...

Medicare Advantage could become the default health-insurance program for all older adults. A recent proposal in Congress would automatically enroll older adults in a Medicare Advantage plan and then ...

Anesthesia providers are grappling with a variety of legislative and policy-related issues that hold implications for patient access, provider compensation and practice staffing. Here are four recent ...

While Stelara is used in fewer indications than Humira, it commands a large market share in its therapeutic areas, most ...

Humana has refiled its lawsuit against the federal government over its Medicare Advantage ratings, with billions of dollars ...

Humana (NYSE:HUM) plans to cut a third of prior authorizations and refiles a case against the government over its 2025 Medicare Star Ratings cut. Read more here.

A federal judge in Texas on Friday tossed a lawsuit brought by Humana that challenged the U.S. government's reduction in the ...

Humana on Monday filed a new lawsuit over the U.S. government's reduction in the health insurer's star ratings for government ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

A federal judge has tossed out a lawsuit from Humana that attempted to reinstate higher quality ratings to its 2025 Medicare ...

The S&P 500 Index ($SPX) (SPY) today down -0.08%, the Dow Jones Industrials Index ($DOWI) (DIA) is down -0.44%, and the ...